Jennison Associates
ATRA icon

Jennison Associates’s Atara Biotherapeutics ATRA Stock Holding History

Jennison Associates’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,228
Closed -$7.05M – 656
2018
Q1 		$7.05M Buy
+7,228
New +$6.59M 0.01% 475
2017
Q2 		– Sell
-1,614
Closed -$829K – 640
2017
Q1 		$829K Buy
+1,614
New +$668K ﹤0.01% 586
2015
Q4 		– Sell
-33,767
Closed -$26.5M – 659
2015
Q3 		$26.5M Buy
33,767
+9,788
+41% +$11.9M 0.03% 397
2015
Q2 		$31.6M Buy
23,979
+189
+0.8% +$217K 0.03% 406
2015
Q1 		$24.7M Buy
23,790
+12,042
+103% +$7.96M 0.02% 422
2014
Q4 		$7.86M Buy
+11,748
New +$7.17M 0.01% 496

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return